These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 16487852)

  • 1. Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.
    Marian AJ; Senthil V; Chen SN; Lombardi R
    J Am Coll Cardiol; 2006 Feb; 47(4):827-34. PubMed ID: 16487852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
    Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
    Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and reversal of cardiac phenotype of human hypertrophic cardiomyopathy mutation cardiac troponin T-Q92 in switch on-switch off bigenic mice.
    Lutucuta S; Tsybouleva N; Ishiyama M; Defreitas G; Wei L; Carabello B; Marian AJ
    J Am Coll Cardiol; 2004 Dec; 44(11):2221-30. PubMed ID: 15582321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.
    Tsybouleva N; Zhang L; Chen S; Patel R; Lutucuta S; Nemoto S; DeFreitas G; Entman M; Carabello BA; Roberts R; Marian AJ
    Circulation; 2004 Mar; 109(10):1284-91. PubMed ID: 14993121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 17β-estradiol prevents cardiac diastolic dysfunction by stimulating mitochondrial function: a preclinical study in a mouse model of a human hypertrophic cardiomyopathy mutation.
    Chen Y; Zhang Z; Hu F; Yang W; Yuan J; Cui J; Hao S; Hu J; Zhou Y; Qiao S
    J Steroid Biochem Mol Biol; 2015 Mar; 147():92-102. PubMed ID: 25541436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.
    Lombardi R; Rodriguez G; Chen SN; Ripplinger CM; Li W; Chen J; Willerson JT; Betocchi S; Wickline SA; Efimov IR; Marian AJ
    Circulation; 2009 Mar; 119(10):1398-407. PubMed ID: 19255346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.
    Lim DS; Lutucuta S; Bachireddy P; Youker K; Evans A; Entman M; Roberts R; Marian AJ
    Circulation; 2001 Feb; 103(6):789-91. PubMed ID: 11171784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental therapies in hypertrophic cardiomyopathy.
    Marian AJ
    J Cardiovasc Transl Res; 2009 Dec; 2(4):483-92. PubMed ID: 20560006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Patel R; Nagueh SF; Tsybouleva N; Abdellatif M; Lutucuta S; Kopelen HA; Quinones MA; Zoghbi WA; Entman ML; Roberts R; Marian AJ
    Circulation; 2001 Jul; 104(3):317-24. PubMed ID: 11457751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.
    Senthil V; Chen SN; Tsybouleva N; Halder T; Nagueh SF; Willerson JT; Roberts R; Marian AJ
    Circ Res; 2005 Aug; 97(3):285-92. PubMed ID: 16020756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial collagen turnover in hypertrophic cardiomyopathy.
    Lombardi R; Betocchi S; Losi MA; Tocchetti CG; Aversa M; Miranda M; D'Alessandro G; Cacace A; Ciampi Q; Chiariello M
    Circulation; 2003 Sep; 108(12):1455-60. PubMed ID: 12952838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.
    Tsoutsman T; Wang X; Garchow K; Riser B; Twigg S; Semsarian C
    J Mol Cell Cardiol; 2013 Sep; 62():164-78. PubMed ID: 23756156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated high-sensitivity troponin T levels are associated with adverse cardiac remodelling and myocardial fibrosis in hypertrophic cardiomyopathy.
    Hasler S; Manka R; Greutmann M; Gämperli O; Schmied C; Tanner FC; Biaggi P; Lüscher TF; Keller DI; Gruner C
    Swiss Med Wkly; 2016; 146():w14285. PubMed ID: 26999566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-Acetylcysteine Influence on Oxidative Stress and Cardiac Remodeling in Rats During Transition from Compensated Left Ventricular Hypertrophy to Heart Failure.
    Reyes DRA; Gomes MJ; Rosa CM; Pagan LU; Damatto FC; Damatto RL; Depra I; Campos DHS; Fernandez AAH; Martinez PF; Okoshi K; Okoshi MP
    Cell Physiol Biochem; 2017; 44(6):2310-2321. PubMed ID: 29258061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
    Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
    Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine.
    Teixeira KC; Soares FS; Rocha LG; Silveira PC; Silva LA; Valença SS; Dal Pizzol F; Streck EL; Pinho RA
    Pulm Pharmacol Ther; 2008; 21(2):309-16. PubMed ID: 17904883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in hemodialysis patients receiving intravenous iron therapy and the role of N-acetylcysteine in preventing oxidative stress.
    Swarnalatha G; Ram R; Neela P; Naidu MU; Dakshina Murty KV
    Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):852-8. PubMed ID: 20814119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in the cardiac metabolome caused by perhexiline treatment in a mouse model of hypertrophic cardiomyopathy.
    Gehmlich K; Dodd MS; Allwood JW; Kelly M; Bellahcene M; Lad HV; Stockenhuber A; Hooper C; Ashrafian H; Redwood CS; Carrier L; Dunn WB
    Mol Biosyst; 2015 Feb; 11(2):564-73. PubMed ID: 25437646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy.
    Konhilas JP; Watson PA; Maass A; Boucek DM; Horn T; Stauffer BL; Luckey SW; Rosenberg P; Leinwand LA
    Circ Res; 2006 Mar; 98(4):540-8. PubMed ID: 16439687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA transcriptome profiling in cardiac tissue of hypertrophic cardiomyopathy patients with MYBPC3 mutations.
    Kuster DW; Mulders J; Ten Cate FJ; Michels M; Dos Remedios CG; da Costa Martins PA; van der Velden J; Oudejans CB
    J Mol Cell Cardiol; 2013 Dec; 65():59-66. PubMed ID: 24083979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.